4 quarters tracked · Beat rate 100% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $4.85 | $5.15 | +6.1% | Beat |
| Q4 2025 | 2025-12-31 | $4.83 | $5.29 | +9.6% | Beat |
| Q3 2025 | 2025-09-30 | $5.11 | $5.64 | +10.3% | Beat |
| Q2 2025 | 2025-06-30 | $5.39 | $6.02 | +11.6% | Beat |
Earnings Beat Rate
Amgen has beaten analyst EPS estimates in 4 of 4 tracked quarters (100% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →